Cancer survivor, Francis, and prospective parents, Nora and Travis, and others like them are our inspiration for delivering next-generation sequencing (NGS) and array-based solutions that help advance health care. Illumina genomic solutions help translational researchers increase their understanding of the role of genetics in disease identification, pathology, prognosis, treatment, and prevention.
We are committed to helping translational and clinical researchers uncover new insights into the biology of cancer that can lead to meaningful advances in its identification and treatment. Our workflow solutions help researchers achieve deep and accurate analysis of a tumor’s molecular profile and accelerate the development of cancer companion diagnostics. Partner with us to help propel progress in personalized oncology.Learn More
Our NGS and array-based solutions help empower informed choices at multiple touch points along the reproductive and health care journey. These will drive translational research to improve IVF success rates, minimize the need for invasive testing procedures, and screen for inherited conditions─that’s just the beginning of what will be possible.Learn More
With the sensitivity, accuracy, and speed of our NGS solutions, researchers can rapidly identify causative variants of inherited disorders by assessing many genes at the same time. The more we know, the more we can do.Learn More
High-resolution, unambiguous human leukocyte antigen (HLA) typing with NGS enables translational researchers to interrogate more of the HLA region. The goal is to reduce the need for additional testing so donor recipients can benefit from more expedient matching.Learn More
To realize the potential of precision medicine, genetic information must be amassed on a large scale. Genotyping data holds immense value for pharmacogenomics, consumer genomics, population studies, and clinical practice.